HRX-233 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

4,112 results for “HRX-233”

Trials

View all 2329 →

A Phase I Clinical Pharmacology Study of TAK-233 in Healthy Subjects

24 participants · First posted Apr 14, 2014

Study Evaluating the Efficacy of DVS-233 in Fibromyalgia

1,050 participants · First posted Mar 10, 2006

Efficacy of a Standardized Centella Asiatica Extract in Patients With Temporomandibular Disorder

23 participants · First posted Jan 30, 2024

Drugs

View all 1400 →

HRX-0233

HRX-215

OP-233

Organizations

View all 35 →

QED Therapeutics, Inc.

United States

Brugmann University Hospital

Belgium

Tuhura Biosciences, Inc.

United States

News

View all 348 →

HepaRegeniX Secures €21.5 Million to Advance Novel Liver Regeneration Therapy

HepaRegeniX Secures €15 Million to Advance HRX-215 for Liver Regeneration

HepaRegeniX's HRX-215 Shows Promise in Liver Regeneration and Preventing Liver Failure

Page 1 of 412